Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Troicki’s Tennis Ban for Missing Blood Test Reduced to 12 Months

Don't Miss Out —
Follow us on:
Tennis Player Viktor Troicki
Tennis player Viktor Troicki said his failure to provide a blood sample was neither intentional nor negligent. Photographer: Adrian Dennis/AFP via Getty Images

Nov. 5 (Bloomberg) -- Sport’s top court reduced tennis player Viktor Troicki’s doping suspension by six months after the judges decided the Serb didn’t purposely fail to provide a blood sample at a tournament in April.

The International Tennis Federation suspended the 27-year-old for 18 months in July, saying he refused to give a blood sample during the Monte Carlo Masters event because he was feeling unwell.

Troicki, who did provide a urine sample, appealed to the Court of Arbitration for Sport in August. He said his failure to provide blood was neither intentional nor negligent. His suspension was reduced to 12 months.

The Lausanne, Switzerland-based CAS ruled that although missing the blood test was still an offense, there was “no suggestion that Mr. Troicki intended to evade the detection of a banned substance in his system.”

The Serb will be permitted to return to the tour on July 15 next year, which means he’ll miss the first three Grand Slams.

Troicki rose to as high as No. 12 in the men’s world rankings in 2011 and reached the fourth round of this year’s French Open. He was ranked 53rd when the ITF suspended him.

To contact the reporter on this story: Ben Priechenfried in London at bprie@bloomberg.net

To contact the editor responsible for this story: Christopher Elser at celser@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.